| The risk epidemic in medical journals JA Skolbekken Social science & medicine 40 (3), 291-305, 1995 | 444 | 1995 |
| Communicating the risk reduction achieved by cholesterol reducing drugs JA Skolbekken Bmj 316 (7149), 1956-1958, 1998 | 153 | 1998 |
| Questions of culture, age and gender in the epidemiology of suicide F Webster Rudmin, M Ferrada‐Noli, JA Skolbekken Scandinavian Journal of Psychology 44 (4), 373-381, 2003 | 150 | 2003 |
| Challenges of informed choice in organised screening W Østerlie, M Solbjør, JA Skolbekken, S Hofvind, AR Saetnan, S Forsmo Journal of medical ethics 34 (9), e5-e5, 2008 | 73 | 2008 |
| We’re not in it for the money—lay people’s moral intuitions on commercial use of ‘their’biobank KS Steinsbekk, LØ Ursin, JA Skolbekken, B Solberg Medicine, Health Care and Philosophy 16, 151-162, 2013 | 70 | 2013 |
| Not worth the paper it's written on? Informed consent and biobank research in a Norwegian context JA Skolbekken, LØ Ursin, B Solberg, E Christensen, B Ytterhus Critical Public Health 15 (4), 335-347, 2005 | 68 | 2005 |
| Unlimited medicalization? Risk and the pathologization of normality JA Skolbekken Health, risk and vulnerability, 26-39, 2007 | 51 | 2007 |
| Experiences of recall after mammography screening—a qualitative study M Solbjør, S Forsmo, JA Skolbekken, AR Sætnan Health care for women international 32 (11), 1009-1027, 2011 | 32 | 2011 |
| Mammography screening and trust: the case of interval breast cancer M Solbjør, JA Skolbekken, AR Sætnan, AI Hagen, S Forsmo Social science & medicine 75 (10), 1746-1752, 2012 | 28 | 2012 |
| General practitioners' attitudes to oestrogen prescription in the menopause: a national survey in Norway B Backe, S Hunskaar, JA Skolbekken Scandinavian Journal of Primary Health Care 10 (3), 179-184, 1992 | 27 | 1992 |
| Surge in publications on early detection B Hofmann, JA Skolbekken Bmj 357, 2017 | 26 | 2017 |
| Women's experiences with mammography screening through 6 years of participation—a longitudinal qualitative study M Solbjør, JA Skolbekken, W Østerlie, S Forsmo Health Care for Women International 36 (5), 558-576, 2015 | 18 | 2015 |
| Pregnancy and substance use – the Norwegian z 10–3 solution.1 Ethical and clinical reflections related to incarceration of pregnant women to protect the foetus … K Söderström, JA Skolbekken Nordic Studies on Alcohol and Drugs 29 (2), 155-171, 2012 | 18 | 2012 |
| Shoulder dystocia–malpractice or acceptable risk? JA Skolbekken Acta obstetricia et gynecologica Scandinavica 79 (9), 750-756, 2000 | 18 | 2000 |
| Cancer patients’ perceived value of a smartphone app to enhance the safety of home-based chemotherapy: feasibility study N Kongshaug, JA Skolbekken, A Faxvaag, E Hofsli JMIR Formative Research 5 (1), e20636, 2021 | 16 | 2021 |
| Could screening participation bias symptom interpretation? An interview study on women's interpretations of and responses to cancer symptoms between mammography screening rounds M Solbjør, JA Skolbekken, AR Sætnan, AI Hagen, S Forsmo BMJ open 2 (6), e001508, 2012 | 16 | 2012 |
| Preparing for and communicating uncertainty in cancer genetic counselling sessions in Norway: An interpretative phenomenological analysis T Aasen, JA Skolbekken Health, Risk & Society 16 (4), 370-389, 2014 | 15 | 2014 |
| The informed consenters: governing biobanks in Scandinavia LØ Ursin, K Hoeyer, JA Skolbekken Biobanks, 177-193, 2008 | 14 | 2008 |
| Risiko som begrep og utfordring i helsevesenet JA Skolbekken Tidsskrift for Den norske legeforening, 1996 | 14 | 1996 |
| «If you give them your little finger, they’ll tear off your entire arm»: losing trust in biobank research L Ursin, B Ytterhus, E Christensen, JA Skolbekken Medicine, Health Care and Philosophy 23, 565-576, 2020 | 13 | 2020 |
Siri ForsmoProfessor/Dean, Faculty of Medicine and Health Sciences, Norwegian University of Science and在 ntnu.no 的电子邮件经过验证
